• Profile
Close

Comparison of selective vs empiric pharmacologic preventative therapy with kidney stone recurrence

Urology Jan 08, 2021

Hsi RS, Yan PL, Goldfarb DS, et al. - Whether an empiric approach to metabolic stone prevention would be effective was determined herein using medical claims from a cohort of working age adults with kidney stone diagnoses (2008-2017). The subset with prescription of thiazides, alkali therapy, or allopurinol—collectively known as preventive pharmacologic therapy (PPT) was identified. Those who underwent 24-hour urine testing before starting PPT (selective therapy) were distinguished from those without it (empiric therapy). A lower hazard of a stone-related event was noted in relation to greater adherence to PPT and older age. Findings revealed that PPT guided by 24-hour urine testing, on average, was not related to a lower hazard of a stone-related event when compared with empiric therapy. These data indicate a requirement to detect kidney stone cases who benefit from 24-hour urine testing.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay